The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Speculative fiction collection offering 14 short stories by Australian and New Zealand authors: Stephen Dedman, Dirk Flinthart, Dave Freer, Michelle Goldsmith, Alex Isle, Lyn McConchie, Claire McKenna, Charlotte Nash, Ian Nichols, Leife Shallcross, Grant Stone, Douglas A Van Belle, Janeen Webb, M Darusha Wehm

Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series

The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.

Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries.

The Code of Federal Regulations is the codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government.

The inside scoop for when you want more than the official line Having a baby is one of life's most joyous-and overwhelming-events. The choices you make now will affect your baby's health long after it is born. How should you change your lifestyle now that you are pregnant? How can you be sure that your baby is developing properly? What should you expect at each doctor's visit? And how on earth will you survive labor? Now thoroughly updated with more than 200 pages of new and completely revised material, including week-by-week pregnancy tips, The Unofficial Guide?TM to Having a Baby gives savvy parents-to-be like you a foolproof appraisal of what works and what doesn't-revealing things even your doctor won't (or can't) tell you, with unbiased recommendations that are not influenced by any company, product, or organization. * Vital Information that other sources can't or won't reveal-including the very latest research on prenatal and genetic testing. * Insider Secrets on how to weather the physical and emotional highs and lows of pregnancy, with tips on health, exercise, sex, and career management. * Money-Saving Tips that help you save on baby gear and maternity wear. * The Latest Trends in new childbirth methods, including Doula care, pain management, and alternative birthing options. * Handy Checklists and Charts to track your baby's development, identify potentially dangerous medications and drugs, and record the milestones in your pregnancy.